Status:
COMPLETED
Lithium Versus Anticonvulsants and the Risk of Physical Disorders
Lead Sponsor:
Mental Health Services in the Capital Region, Denmark
Conditions:
Bipolar Disorder
Eligibility:
All Genders
5-100 years
Brief Summary
Nationwide population-based register linkage study covering the entire 5.9 million inhabitants in Denmark systematically investigating the associations between sustained long-term use of lithium versu...
Detailed Description
The study includes two cohorts. Cohort 1: all 12.607 patients with a diagnosis of bipolar disorder (ICD-10 code: DF30-31.9) who subsequently were exposed to either lithium, lamotrigine or valproate be...
Eligibility Criteria
Inclusion
- diagnosis of bipolar disorder and subsequent exposure to either lithium, lamotrigine or valproate
Exclusion
- None
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
169285 Patients enrolled
Trial Details
Trial ID
NCT06005155
Start Date
June 1 2022
End Date
July 1 2023
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric Center Copenhagen
Copenhagen, Denmark, 2000